Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $488.6300 (-0.91%) ($488.6300 - $488.6300) on Thu. Mar. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.34% (three month average) | RSI | 78 | Latest Price | $488.6300(-0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.5% a day on average for past five trading days. | Weekly Trend | REGN advances 8.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(42%) IWF(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.17% in a week (0% probabilities). VIXM(-24%) VXX(-11%) TLT(-5%) SHY(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.17% (StdDev 2.34%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $470.43(3.87%) | 10 Day Moving Average | $452.93(7.88%) | 20 Day Moving Average | $425.54(14.83%) | To recent high | -0.9% | To recent low | 45.4% | Market Cap | $51.809b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |